• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢他啶与成人严重感染的概率性治疗]

[Ceftazidime and probabilistic treatment of severe infections in adults].

作者信息

Potel G, Touze M D, Baron D

机构信息

Laboratoire d'Antibiologie expérimentale et clinique, Faculté de Médecine, Nantes.

出版信息

Presse Med. 1988 Oct 26;17(37):1981-4.

PMID:2973602
Abstract

Probability antibiotic treatments are based on two "best guesses": the nature of the responsible organism and its resistance phenotype. Such treatments are justified in immunocompetent patients with severe infection. The microbiological and pharmacokinetic properties of third generation cephalosporins, and notably ceftazidime, are such that their use as single or combined therapy can be determined. A very wide spectrum and a tendency towards a stronger bactericidal effect are in favour of monotherapy preceded by a short course of bitherapy, especially in cases of hospital-acquired infections.

摘要

抗生素治疗方案基于两种“最佳猜测”:致病微生物的种类及其耐药表型。对于免疫功能正常的重症感染患者,这种治疗方法是合理的。第三代头孢菌素,尤其是头孢他啶的微生物学和药代动力学特性,使其作为单一疗法或联合疗法的应用成为可能。抗菌谱极广且杀菌作用更强的趋势有利于在短期双药联合治疗后采用单一疗法,尤其是在医院获得性感染的情况下。

相似文献

1
[Ceftazidime and probabilistic treatment of severe infections in adults].[头孢他啶与成人严重感染的概率性治疗]
Presse Med. 1988 Oct 26;17(37):1981-4.
2
[Probabilistic treatment with ceftazidime of severe infections in children].[头孢他啶对儿童严重感染的概率性治疗]
Presse Med. 1988 Oct 26;17(37):1985-7.
3
[Empirical antibiotic therapy and ceftazidime].[经验性抗生素治疗与头孢他啶]
Presse Med. 1988 Oct 26;17(37):1977-80.
4
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.评估抑制曲线下面积(AUIC)和高于最低抑菌浓度的时间(T>MIC)作为头孢吡肟和头孢他啶治疗严重细菌感染疗效预测指标的研究
Int J Antimicrob Agents. 2008 Apr;31(4):345-51. doi: 10.1016/j.ijantimicag.2007.12.009. Epub 2008 Mar 4.
5
[Experiences with ceftazidime in the therapy of neonatal infections].[头孢他啶治疗新生儿感染的经验]
Infection. 1987;15 Suppl 4:S209-13. doi: 10.1007/BF01645873.
6
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
7
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.
8
Ceftazidime in neonatal infections.头孢他啶用于新生儿感染
Arch Dis Child. 1985 Apr;60(4):360-4. doi: 10.1136/adc.60.4.360.
9
Preliminary experience with ceftazidime monotherapy in perinatal infection.头孢他啶单药治疗围产期感染的初步经验。
Helv Paediatr Acta. 1987;42(4):297-303.
10
Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.头孢吡肟与头孢他啶:危重症患者经验性用药的考量
Int J Antimicrob Agents. 2007 Feb;29(2):117-28. doi: 10.1016/j.ijantimicag.2006.08.031. Epub 2006 Dec 8.

引用本文的文献

1
The central melanocortin system and human obesity.中央黑皮质素系统与人类肥胖。
J Mol Cell Biol. 2020 Oct 1;12(10):785-797. doi: 10.1093/jmcb/mjaa048.